OncoStem

OncoStem Develops Tests to Identify Patterns of Cancer Recurrence Risk. Understanding these patterns ensures patients receive personalized therapies and treatments best suited for their condition. Founded in 2011, OncoStem aims to develop innovative tests to personalize cancer treatment. Understanding tumor biology helps physicians optimize treatment methods for cancer patients. Our flagship product, CanAssist Breast, has been launched for breast cancer. Currently, similar tests are being developed for other cancer types, including oral and ovarian cancer. Research is ongoing to identify and characterize novel drug targets for breast and oral cancer.